In August of 2022, FDA announced the approval of Auvelity, the first oral NMDA receptor antagonist approved for the treatment of major depressive disorder (MDD) in adults.

Lauren Walters, PharmD

Ever since FDA amended the EUAs in late August 2022 for the Moderna COVID-19 vaccine and the Pfizer–BioNTech COVID-19 vaccine to authorize bivalent formulations of the vaccines for use as a booster dose, patients have had questions.

Bella Blankenship, PharmD

Spirulina is a blue-green cyanobacterium that’s found and farmed in fresh and marine waters worldwide.

Mickie Cathers

The common cold, a viral infection of the upper respiratory tract, affects millions of Americans each year.

Mary Warner

Updates from FDA

APhA Staff